Auckland, Grafton Clinical Trials

A listing of Auckland, Grafton clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 157 clinical trials
Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System (INFINITE-OUS)

To evaluate the safety and effectiveness of the BlueLeaf System for the restoration of venous competence for the treatment of symptomatic chronic venous insufficiency (CVI).

compression therapy
venous reflux
reflux
  • 76 views
  • 02 Mar, 2022
  • 5 locations
Respiratory Emissions in Healthy Participants

This is an randomised cross over trial in healthy participants measuring respiratory emissions during different respiratory activities.

Accepts healthy volunteers
  • 1 views
  • 16 May, 2022
  • 1 location
A Study to Evaluate the Safety and Tolerability of KJ103 in Healthy Adults

This is a randomized, single-blinded, placebo controlled, single ascending dose phase I study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) and immunogenicity of KJ103 in healthy subjects.

Accepts healthy volunteers
  • 6 views
  • 17 Jun, 2022
  • 1 location
A Study to Evaluate HB0034 in Healthy Adult Participants

The aim of this study is to investigate the safety and tolerability of HB0034 in healthy subjects following a single dose.

Accepts healthy volunteers
  • 1 views
  • 26 May, 2022
  • 1 location
A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

The SUMMIT MAX study is a prospective, randomized, controlled, interventional clinical trial to evaluate the safety and effectiveness of the Route 92 Medical MonoPoint® Reperfusion System for aspiration thrombectomy in acute ischemic stroke patients.

  • 0 views
  • 11 Jul, 2022
  • 9 locations
A Study Comparing Two Different Capsules, APL-101 and PLB-1001 Capsules, in Healthy Chinese and Caucasian Participants

This is a Phase 1, open-label, multi-center, randomized, 2-period, adaptive design, crossover study to assess the bioequivalence of APL-101 (Vebreltinib) capsules and PLB-1001 (Bozitinib) capsules. The treatments to be administered orally in this study include: Treatment A (reference): Two 100 mg APL-101 (Vebreltinib) capsules (200 mg dose), manufactured for Apollomics, …

Accepts healthy volunteers
  • 0 views
  • 30 Jun, 2022
  • 1 location
Pharmacokinetic Study Comparing MB05 (Proposed Palivizumab Biosimilar), EU-sourced Synagis® and US-sourced Synagis® in Healthy Volunteers.

Randomized, double blind, parallel group, single dose, 3 arm study to investigate and compare the pharmacokinetics (PK), safety, immunogenicity and tolerability of MB05 with US and EU Synagis® in healthy subjects. During the course of the study, the similarity in pharmacokinetics will be assessed by sampling the levels of drug …

Accepts healthy volunteers
  • 0 views
  • 07 Jul, 2022
  • 1 location
NTLA-2002 in Adults With Hereditary Angioedema (HAE) (NTLA-2002)

This study will be conducted to evaluate the safety, tolerability, activity, pharmacokinetics, and pharmacodynamics of NTLA-2002 in adults with Hereditary Angioedema (HAE).

angioedema
  • 0 views
  • 26 Jul, 2022
  • 3 locations
Biosimilar Study Comparing PK, PD, Safety and Immunogencity of BP11 With US Licensed Xolair and EU Approved Xolair

A single dose, double blind comparative trial to assess the pharmacokinetics, pharmacodynamics, safety and immunogenicity of 3 different products (BP11, US-Xolair and EU-Xolair) containing 150mg of Omalizumab as subcutaneous injection in healthy male volunteers.

Accepts healthy volunteers
  • 0 views
  • 06 May, 2022
  • 2 locations
A Phase 1b/2 Study of BGB-11417in Monotherapy and in Various Combinations With Dexamethasone and Carfilzomib in Multiple Myeloma

Study consists of two parts, a part 1 dose escalation and a part 2 cohort expansion in combination with dexamethasone and carfilzomib intravenously across two cohorts with a monotherapy component as well.

  • 0 views
  • 25 Jul, 2022
  • 8 locations